Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum.

about

Porcine C-peptide measurement to assess graft function in xenogeneic porcine islet transplantation; editorial commentary.Xenotransplantation literature update, September/October 2017.

P2860

Q48338660-50C73413-3AED-4DF1-8A4B-6835F13D88D8 Q49720148-98ED44F4-92CB-410D-870F-12D12CB5198A

P2860

Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum.

Item

http://www.wikidata.org/entity/Q38668312

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cross-validation of commercial ...... ts in non-human primate serum.

@en

type

Item

label

Cross-validation of commercial ...... ts in non-human primate serum.

@en

prefLabel

Cross-validation of commercial ...... ts in non-human primate serum.

@en

P1476

Cross-validation of commercial ...... ts in non-human primate serum.

@en

P2093

Jody L Janecek

http://www.w3.org/2001/XMLSchema#string

Lucas A Mutch

http://www.w3.org/2001/XMLSchema#string

Rebecca L Hegstad-Davies

http://www.w3.org/2001/XMLSchema#string

Sarah C Gresch

http://www.w3.org/2001/XMLSchema#string

P2860

First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 4: pre-clinical efficacy and complication data required to just

The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 4: Pre-clinical efficacy and complication data required to justify a clinical t

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.

The proinsulin C-peptide--a multirole model

Successful implementation of cooperative handling eliminates the need for restraint in a complex non-human primate disease model.

CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.

Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model.

The usefulness and limitations of the diabetic macaque model in evaluating long-term porcine islet xenograft survival.

Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression.

Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection.

P31

scholarly article

P356

10.1111/XEN.12320

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melanie L. Graham

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28731212

http://www.w3.org/2001/XMLSchema#string

Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum.

about

P2860

P2860

Cross-validation of commercial enzyme-linked immunosorbent assay and radioimmunoassay for porcine C-peptide concentration measurements in non-human primate serum.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698